Andere talen Numinus Wellness Inc.

Aandelen

NUMI

CA67054W1032

Beurs gesloten - Toronto S.E. Andere beurzen 21:47:55 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,075 ^CAD	-.--%		-11,76%	-31,82%

17/04	Cybin selecteert Cedar Clinical Research van Numinus Wellness Inc. als klinische onderzoekslocatie voor haar Fase 3 studie van CYB003	CI
15/04	Transcript : Numinus Wellness Inc., Q2 2024 Earnings Call, Apr 15, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Numinus Wellness Brief: Says Cedar Clinical Research Selected as clinical research site for Cybin's Phase 3 Study of CYB003	17/04
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003	17/04
Cybin Selects Numinus Wellness Inc.'s Cedar Clinical Research as clinical research site for Its Phase 3 Study of CYB003	17/04
Numinus Wellness Drops 25% as it Explores Options for its Canadian Operations; FQ2 Profit Falls	15/04
Toronto Stocks Edge Lower; Parkland Shares Up After Rebuffing Call for Strategic Review	15/04
Numinus Wellness Exploring Options For Canadian Operations; Comes After It Posted QoQ Decrease in Q2 Revenue, Gross Profit	15/04
Numinus Wellness Brief: Co Has decided to Explore Opportunities to "Redefine, divest and/or discontinue" its Canadian clinical operations	15/04
Numinus Wellness Brief: Says To Focus on U.S. operations and Citing "Strategic Adjustments" in its Canadian Market Presence	15/04
Numinus Wellness Provides Corporate Update	15/04
Numinus Wellness Provides Corporate Update	15/04
Numinus Wellness Posts QoQ Decrease in Q2 Revenue, Gross Profit	15/04
An undisclosed buyer agreed to acquire Canadian clinical operations from Numinus Wellness Inc..	15/04
Numinus Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	13/04
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results	13/04
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results	13/04
Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024	09/04
PharmAla Biotech Signs Sale Agreement with Numinus Wellness	26/03
Numinus Wellness Submits Clinical Trial Application to Health Canada	20/03
Numinus Wellness Brief: Says Submitted Clinical Trial Application	20/03
Numinus Wellness Submits Clinical Trial Application	20/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Numinus Wellness Inc.

Aandelen

NUMI

CA67054W1032

Andere talen

Filters